Form 4 for WGS GeneDx Holdings Corp.
Accepted 2024-12-03 00:00:00 ET · period of report 2024-12-01 · accession 0001415889-24-028197 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-12-03 | 2024-12-01 | WGS | Feeley Kevin | CFO | M - OptEx | $0.00 | +718 | 23.7K | +3% | $0 |
| D | 2024-12-03 | 2024-12-02 | WGS | Feeley Kevin | CFO | S - Sale+OE | $78.39 | -263 | 23.4K | -1% | -$20.6K |
| D | 2024-12-03 | 2024-12-01 | WGS | Feeley Kevin | CFO | M - OptEx | $0.00 | -718 | 5,021 | -13% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-12-01 | M | A | 718 | $0.00 | 23,669 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. |
| 2 | Common | Class A Common Stock | 2024-12-02 | S | D | 263 | $78.39 | 23,406 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2024-12-01 | M | D | 718 | $0.00 | 5,021 | D | — · — to — | 718 Class A Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. (F3) 6.25% vest in quarterly installments over the 4-year period commencing on December 1, 2022 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date. |